Omalizumab facilitates rapid oral desensitization for peanut allergy

BACKGROUND: Peanut oral immunotherapy (OIT) is a promising approach to peanut allergy but reactions are frequent and some patients cannot be desensitized. The anti-IgE medication omalizumab (Xolair) may allow more rapid peanut updosing and decrease reactions. OBJECTIVE: To evaluate if omalizumab fac...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:J Allergy Clin Immunol
Main Authors: MacGinnitie, Andrew J., Rachid, Rima, Gragg, Hana, Little, Sara V, Lakin, Paul, Cianferoni, Antonella, Heimall, Jennifer, Makhija, Melanie, Robison, Rachel, Chinthrajah, R. Sharon, Lee, John, Lebovidge, Jennifer, Dominguez, Tina, Rooney, Courtney, Lewis, Megan Ott, Koss, Jennifer, Burke-Roberts, Elizabeth, Chin, Kimberly, Logvinenko, Tanya, Pongracic, Jacqueline A., Umetsu, Dale T., Spergel, Jonathan, Nadeau, Kari C., Schneider, Lynda C.
Format: Artigo
Sprog:Inglês
Udgivet: 2016
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5369605/
https://ncbi.nlm.nih.gov/pubmed/27609658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jaci.2016.08.010
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker